Robert Flavell, Md, Phd
Clinical trials sponsored by Robert Flavell, Md, Phd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New imaging agent could spot hidden myeloma cells Results expected Jan 2027 (estimated)
- New scan could spot deadliest prostate cancers Results expected Jul 2027 (estimated)
-
New imaging agent could spot hidden myeloma cells
Diagnosis Recruiting nowThis early-stage study tests a new radioactive tracer called [89Zr]DFO-YS5 for PET scans to find multiple myeloma cells that have a specific protein (CD46). About 20 adults with confirmed multiple myeloma will receive the tracer and have a PET scan. The goal is to see if this met…
Phase 1 • Sponsor: Robert Flavell, MD, PhD • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
New PET tracer could light up tumors for better cancer imaging
Knowledge-focused Recruiting nowThis early-phase study tests a new radioactive tracer called [89Zr]DFO-starPEG to see if it can make tumors show up better on PET scans. The goal is to learn how the tracer behaves in the body and whether it can help doctors see the "leakiness" of tumor blood vessels, which may g…
Phase 1 • Sponsor: Robert Flavell, MD, PhD • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC